Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015

Euro Surveill. 2015 Feb 5;20(5):21024. doi: 10.2807/1560-7917.es2015.20.5.21024.

Authors

S A McNeil¹, M K Andrew, L Ye, F Haguinet, T F Hatchette, M ElSherif, J LeBlanc, A Ambrose, A McGeer, J E McElhaney, M Loeb, D MacKinnon-Cameron, R Sharma, G Dos Santos, V Shinde; Investigators of the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN)

Affiliation

¹ Canadian Center for Vaccinology, IWK Health Centre and Capital Health, Dalhousie University, Halifax, Nova Scotia, Canada.

PMID: 25677052
DOI: 10.2807/1560-7917.es2015.20.5.21024

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Canada / epidemiology
Case-Control Studies
Female
Hospitalization / statistics & numerical data*
Humans
Influenza A Virus, H3N2 Subtype / immunology
Influenza A Virus, H3N2 Subtype / isolation & purification*
Influenza Vaccines / administration & dosage*
Influenza Vaccines / immunology
Influenza, Human / epidemiology
Influenza, Human / prevention & control*
Male
Middle Aged
Outcome Assessment, Health Care*
Population Surveillance
Seasons
Sentinel Surveillance
Vaccination
Young Adult

Substances

Influenza Vaccines

Grants and funding